IOL Chemicals releases Q4 FY26 call audio recording

IOL Chemicals & Pharmaceuticals has released the audio recording of its analyst and investor conference call regarding the financial results for Q4 FY26. The call was originally held on Friday, 22nd May 2026, under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Access Details

The audio recording is now available for stakeholders to review the management's discussion on the company's financial performance for the quarter. The recording can be accessed directly through the link provided on the official company website.

Management Participation

The conference call featured participation from key senior management representatives, including Mr. Pardeep Kumar Khanna, Chief Financial Officer, and Mr. Abhay Raj Singh, Sr. Vice President & Company Secretary. Other participants included Mr. Kushal Kumar Rana, Director Works, and Mr. Rakesh Mahajan, Finance Advisor & Strategic Head.

Investor Contact

For further queries regarding the financial results or the conference call, investors may contact the designated investor relations coordinator at MUFG Intime India Pvt. Ltd.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
-3.42%	+19.32%	+47.46%	+43.45%	+50.74%	+1.38%

IOL Chemicals & Pharmaceuticals has announced that it will hold an investor meet in accordance with Regulation 30. The meeting is scheduled for May 29, 2026. The company has not yet released specific details regarding the agenda or the participants who will be in attendance.

Meeting Details

The investor meet is a formal session organized by the company to engage with its investors and provide updates on its business operations. The disclosure was made to ensure compliance with regulatory requirements regarding timely information dissemination.

Event	Date
Investor Meet	May 29, 2026

Regulatory Context

The announcement was made under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations. This regulation mandates listed companies to disclose any material events or information that could influence the decision-making of investors. Further details regarding the specific matters to be discussed are expected to be released in due course.